In this context, the present paper deals with the evaluation of SPARC expression during ductal breast carcinoma progression, from the dysplastic lesion until bone metastasis establishment: SPARC distribution in neoplastic cells versus stroma, and the plasma levels were examined. This evidence concerns the gene SPARC and breast ductal adenocarcinoma.